Fidelis Capital Partners’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.63M Buy
7,691
+39
+0.5% +$8.4K 0.12% 154
2025
Q4
$1.57M Sell
7,652
-272
-3% -$51.2K 0.11% 147
2025
Q3
$1.24M Buy
7,924
+5,923
+296% +$915K 0.1% 166
2025
Q2
$313K Buy
2,001
+64
+3% +$9.5K 0.03% 340
2025
Q1
$266K Buy
1,937
+3
+0.2% +$382 0.03% 343
2024
Q4
$242K Buy
+1,934
New +$226K 0.02% 375

Other funds holding CAH

Fidelis Capital Partners's CAH Position: Q1 2026 in Review

Fidelis Capital Partners increased its Cardinal Health (CAH) stake by 0.51% in Q1 2026, buying an estimated $8.4K and bringing the position to 7,691 shares worth $1.63M. The position accounts for 0.12% of the portfolio, ranked #154.

Fidelis Capital Partners first reported a position in CAH in Q4 2024 and has held it in 6 quarters since. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Fidelis Capital Partners held 7,691 shares of Cardinal Health worth $1.63M as of Q1 2026.
  • Fidelis Capital Partners bought 39 Cardinal Health shares in Q1 2026, an estimated $8.4K.
  • Cardinal Health made up 0.12% of Fidelis Capital Partners's portfolio in Q1 2026, its #154 holding.
  • Fidelis Capital Partners first reported a position in Cardinal Health in Q4 2024 and has held it in 6 quarters since.
  • 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Fidelis Capital Partners's 13F filing for Q1 2026, filed 6 May 2026.